Skip to main content

Advertisement

Table 2 Characteristics of survey respondents (n = 1140)

From: Management of chronic spontaneous urticaria: a worldwide perspective

Characteristics of respondents Geographical regions Total
% (n)
NA
% (n/total)
LA
% (n/total)
EU
% (n/total)
AME
% (n/total)
AP
% (n/total)
Specialtya (n = 1138)
 Allergists/ Clinical Immunologists 98.2 (324/330) 97.4 (187/192) 83.1 (315/379) 79.7 (51/64) 76.9 (133/173) 88.7 (1010)
 Dermatologists 0.3 (1/330) 0.5 (1/192) 9.8 (37/379) 0 6.9 (12/173) 4.5 (51)
 Pediatricians 4.2 (14/330) 25.5 (49/192) 17.4 (66/379) 23.4 (15/64) 25.4 (44/173) 16.5 (188)
 General Practitioners 0.6 (2/330) 3.1 (6/192) 1.6 (6/379) 6.2 (4/64) 4 (7/173) 2.2 (25)
Gender (n = 1117)
 Male 58.5 (189/323) 55.1 (102/185) 43.7 (163/373) 57.1 (36/63) 58.4 (101/173) 53.0 (591)
 Female 41.5 (134/323) 44.9 (83/185) 56.3 (210/373) 42.9 (27/63) 41.6 (72/173) 47.0 (526)
Age, years (n = 1132)
 < 40 22.9 (75/327) 27.6 (53/192) 28.2 (106/376) 17.2 (11/64) 23.1 (133/173) 25.2 (285)
 ≥40 77.1 (252/327) 72.4 (139/192) 71.8 (270/376) 82.8 (53/64) 76.9 (133/173) 74.8 (847)
Clinical experience, years (n = 1130)
 ≤19 50.3 (164/326) 53.9 (104/193) 58.2 (217/373) 60.9 (39/64) 63.2 (110/174) 56.1 (634)
 Over 19 49.7 (162/326) 46.1 (89/193) 41.8 (156/373) 39.1 (25/64) 36.8 (64/174) 43.9 (496)
Place of worka (n = 1140)
 Private practice 63.9 (211/330) 82.4 (159/193) 34.6 (131/379) 54.7 (35/64) 46.0 (80/174) 54.0 (616)
 University clinic 70.3 (232/330) 68.4 (132/193) 57.5 (218/379) 59.4 (38/64) 71.8 (125/174) 65.3 (745)
 Hospital 11.8 (39/330) 39.4 (76/193) 43.3 (164/379) 42.2 (27/64) 58.6 (102/174) 35.8 (408)
 Specialized urticaria centre 0.9 (3/330) 4.7 (9/193) 2.9 (11/379) 3.1 (2/64) 0.3 (3/174) 2.4 (28)
Department (n = 1140)
 Outpatients 97.3 (321/330) 89.6 (173/193) 82.3 (312/379) 81.3 (52/64) 89.1 (155/174) 88.9 (1013)
 Inpatients 0.9 (3/330) 8.8 (17/193) 12.4 (47/379) 10.9 (7/64) 6.9 (12/174) 7.5 (86)
 Outpatients and inpatients 1.8 (6/330) 1.6 (3/193) 5.3 (20/379) 7.8 (5/64) 4.0 (7/174) 3.6 (41)
Age of patients (n = 1131)
 Adults 16.5 (54/327) 17.2 (33/192) 42.0 (158/376) 10.9 (7/64) 30.8 (53/172) 27.0 (305)
 Children 9.5 (31/327) 16.7 (32/192) 19.4 (73/376) 18.8 (12/64) 27.9 (71/172) 19.3 (219)
 Adults and children 74.0 (242/327) 66.1 (127/192) 38.6 (145/376) 70.3 (45/64) 41.3 (48/172) 53.7 (607)
Number of CSU patients per week (n = 1127)
< 10 75.5 (247/327) 78.8 (152/193) 80.7 (302/374) 71.0 (44/62) 78.4 (134/171) 78.0 (879)
≥10 24.5 (80/327) 21.2 (41/193) 19.3 (72/374) 29.0 (18/62) 21.6 (37/171) 22.0 (248)
Patients with angioedema, % from the total number of CSU patients (n = 1131)
 ≤20 37.7 (123/326) 58.5 (113/193) 51.7 (195/377) 55.6 (35/63) 66.3 (114/172) 51.3 (580)
 > 20 62.3 (203/326) 41.5 (80/193) 48.3 (182/377) 44.4 (28/63) 33.7 (58/172) 48.7 (551)
Adherence to the urticaria guidelinesa (n = 1126)
 Follow the guidelines Any of three below 88.0 (286/325) 93.8 (180/192) 97.3 (365/375) 85.7 (54/63) 89.5 (153/171) 92.2 (1038)
EAACI/WAO/GA2LEN/EDF 16.3 (53/325) 78.1 (150/192) 82.4 (309/375) 68.3 (43/63) 63.2 (108/171) 58.9 (663)
US practice parameters 81.2 (264/325) 32.3 (62/192) 9.1 (34/375) 28.6 (18/63) 29.8 (51/171) 38.1 (429)
National 7.1 (23/325) 26.0 (50/192) 32.5 (122/375) 14.3 (9/63) 30.4 (52/171) 22.7 (256)
Follow any but deviate 40.0 (80/200) 28.1 (25/89) 49.4 (79/160) 58.1 (18/31) 53.8 (49/91) 22.3 (251)
 Do not follow 12.0 (39/325) 6.3 (12/192) 2.7 (10/375) 14.3 (9/63) 10.5 (18/171) 7.8 (88)
  1. AME Africa/Middle-East, AP Asia-Pacific, EU Europe, LA Latin America, NA North America. arespondents could choose more than one option